Probiotics

Digestive Diseases

Volumn 31, Issue 3-4, 2013, Pages 385-387

  Kruis, Wolfgang ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Inflammatory bowel disease; Microbiota; Probiotics; Treatment

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; MESALAZINE; PLACEBO; PREDNISOLONE; PROBIOTIC AGENT; VSL3;

ADD ON THERAPY; ANTIBIOTIC PROPHYLAXIS; BIFIDOBACTERIUM BIFIDUM; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CROHN DISEASE; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; ILEITIS; INTESTINE SURGERY; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RELAPSE; REMISSION; SECONDARY PREVENTION; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; POUCHITIS; ABDOMINAL SURGERY; ILEUM POUCH; INFLAMMATORY BOWEL DISEASE; THERAPY EFFECT;

COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; POUCHITIS; PROBIOTICS; REMISSION INDUCTION;

EID: 84888235196     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000354706     Document Type: Conference Paper

References (20)

1. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-1623.
2. Metchnikoff E: Essais optimists; in Mitchell PC (ed): Classics in Longevity and Aging (Series). New York, Putnam, 1908.
3. Guarner F, Schaafsma GJ: Probiotics. Int J Food Micobiol 1998; 39: 237-238.
4. Nissle A: Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klinik 1918; 2: 29-33.
5. Holly H, Harris J, Lyon E, Beal J, Foey AD: Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 2013,5: 1869-1912.
6. Besselink MG, van Santvoort HC, Buskens E, et al: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-659.
7. Shanahan F, Collins SM: Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin North Am 2010; 39: 721-726.
8. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635-639.
9. Jonkers D, Penders J, Masclee A, Pierik M: Probiotics in the management of inflammatory bowel disease a systematic review of intervention studies in adult patients. Drugs 2012; 72: 803.
10. Cui HH, Chen CL, Wang JD, et al: Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004; 10: 1521-1525.
11. Kruis W, Fric P, Pokrotnieks J, et al: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623.
12. Kruis W, Schutz E, Fric P, et al: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853-858.
13. Travis SP, Stange EF, Lemann M, et al: European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008; 2: 1-32.
14. Malchow HA: Crohn's disease and Escherichia coli : a new approach in therapy to maintain remission of colonic Crohn's disease J Clin Gastroenterol 1997; 25: 653-658.
15. Guslandi M, Mezzi G, Sorghi M, et al: Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000; 45: 1462-1464.
16. Schultz M, Timmer A, Herfarth HH, et al: Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004; 4: 5.
17. Prantera C, Scribano ML, Falasco G, et al: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut 2002; 51: 405-409.
18. Marteau P, Lemann M, Seksik P, et al: Ineffectiveness of Lactobacillus johnsonii LAI for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial. Gut 2006; 55: 842-847.
19. Van Gossum A, Dewit O, Louis E, et al: Multicenter randomized-controlled clinical trial of probiotics ( Lactobacillus johnsonii , LAI) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection. Inflamm Bowel Dis 2007; 13: 135-142.
20. Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 2010; 10:13.